RMED insider filings
Ra Medical Systems, Inc. — 37 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-27. Screen RMED transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for RMED between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — Ra Medical Systems, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-27 | 4 | Meline Susanne — Director | Conversion (C): 2,575 @ $0 · Grant/award (A): 14.06 (derivative) @ $0 · Conversion (C): 2.58 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | Caruso James Joseph — Director | Conversion (C): 1,779 @ $0 · Conversion (C): 1.78 (derivative) @ $0 | EDGAR |
| 2023-03-27 | 4 | JENKINS DAVID A — Ex. Chairman of the Board, Director | Conversion (C): 277,597 @ $0 · Conversion (C): 709,703 @ $0 · Conversion (C): 2,264 @ $0 · Conversion (C): 277.60 (derivative) @ $0 · Conversion (C): 709.70 (derivative) @ $0 · Conversion (C): 2.26 (derivative) @ $0 | EDGAR |
| 2023-03-15 | 4 | McGuire Jonathan Will — CEO & Secretary, Director | Tax withholding (F): 84 @ $2.67 | EDGAR |
| 2023-01-11 | 4 | Caruso James Joseph — Director | Grant/award (A): 9.71 (derivative) | EDGAR |
| 2023-01-11 | 4 | JENKINS DAVID A — Executive Chairman of Board, Director | Grant/award (A): 2,569.94 (derivative) · Grant/award (A): 20.95 (derivative) · Grant/award (A): 6,570.24 (derivative) | EDGAR |
| 2022-05-24 | 4 | Jackson Andrew C. — CFO | Tax withholding (F): 1,361 @ $0.30 | EDGAR |
| 2022-05-24 | 4 | McGuire Jonathan Will — Chief Executive Officer, Director | Tax withholding (F): 4,241 @ $0.30 | EDGAR |
| 2021-11-24 | 4 | Jackson Andrew C. — CFO | Disposition to issuer (D): 11,759 @ $0 · Sale (S): 2,684 @ $2.62 | EDGAR |
| 2021-11-24 | 4 | McGuire Jonathan Will — Chief Executive Officer, Director | Disposition to issuer (D): 34,752 @ $0 · Sale (S): 8,149 @ $2.62 | EDGAR |
| 2021-06-08 | 4 | Meline Susanne — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-06-08 | 4 | ENQUIST WILLIAM R — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-06-08 | 4 | Stafslien Joan — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-06-08 | 4 | Mejia Richard Jr — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-06-08 | 4 | COLOMBATTO MARTIN J — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-05-24 | 4 | McGuire Jonathan Will — Chief Executive Officer, Director | Tax withholding (F): 216 @ $3.15 | EDGAR |
| 2021-02-05 | 4 | Meline Susanne — Director | Grant/award (A): 4,000 @ $0 | EDGAR |
| 2021-01-07 | 4 | ENQUIST WILLIAM R — Director | Grant/award (A): 7,243 @ $0 | EDGAR |
| 2021-01-07 | 4 | Mejia Richard Jr — Director | Grant/award (A): 9,423 @ $0 | EDGAR |
| 2021-01-07 | 4 | Saad Mark E — Director | Grant/award (A): 8,227 @ $0 | EDGAR |
| 2021-01-07 | 4 | COLOMBATTO MARTIN J — Director | Grant/award (A): 10,000 @ $0 | EDGAR |
| 2020-11-24 | 4 | Horwood Daniel — General Counsel | Grant/award (A): 200 @ $5.43 | EDGAR |
| 2020-11-24 | 4 | Jackson Andrew C. — CFO | Grant/award (A): 200 @ $5.43 | EDGAR |
| 2020-11-24 | 4 | Kraws Jeffrey J — Co-President | Grant/award (A): 200 @ $5.43 | EDGAR |
| 2020-11-24 | 4 | McGuire Jonathan Will — Chief Executive Officer, Director | Tax withholding (F): 216 @ $6.39 | EDGAR |
| 2020-11-23 | 4 | ENQUIST WILLIAM R — Director | Purchase (P): 5,263 @ $5.82 | EDGAR |
| 2020-11-23 | 4 | Mejia Richard Jr — Director | Purchase (P): 1,000 @ $5.82 | EDGAR |
| 2020-11-19 | 4 | Horwood Daniel — General Counsel | Grant/award (A): 19,591 @ $0 | EDGAR |
| 2020-11-19 | 4 | Jackson Andrew C. — CFO | Grant/award (A): 35,276 @ $0 | EDGAR |
| 2020-11-19 | 4 | Stafslien Joan — Director | Purchase (P): 4,410 @ $5.67 | EDGAR |
| 2020-11-19 | 4 | McGuire Jonathan Will — Chief Executive Officer, Director | Grant/award (A): 104,254 @ $0 | EDGAR |
| 2020-11-19 | 4 | COLOMBATTO MARTIN J — Director | Purchase (P): 8,700 @ $5.78 | EDGAR |
| 2020-10-14 | 4 | ENQUIST WILLIAM R — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2020-10-14 | 4 | Stafslien Joan — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2020-10-14 | 4 | Mejia Richard Jr — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2020-10-14 | 4 | Saad Mark E — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2020-10-14 | 4 | COLOMBATTO MARTIN J — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
Recent 8-K events — Ra Medical Systems, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-14 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-09 | 8-K | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-05 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-10-02 | 8-K | 3.03 — Material Modification to Rights of Security Holders 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-25 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-31 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-29 | 8-K/A | 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-15 | 8-K | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=RMED returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs